Frank Conrad

Title: Innovations of Frank Conrad in Hematology

Introduction

Frank Conrad, an innovative inventor based in Frankfurt-am-Main, Germany, has made significant contributions to the field of hematology through his research and inventions. With a total of two patents to his name, Conrad focuses on improving the properties of stored erythrocytes, which is crucial for medical applications, including blood transfusions and various blood-related disorders.

Latest Patents

Conrad's latest patents include a pioneering method for enhancing the viability of stored erythrocytes by utilizing D,L-alpha-lipoic acid and its enantiomers and derivatives. His invention addresses crucial issues related to oxygen release capacity, viscoelasticity, and erythrocyte aggregability. The application of these substances results in increased resistance to membrane peroxidation during storage and combats damage caused by the freeze/thaw process. Additionally, he has developed a method focused on the use of various forms of alpha-lipoic acid to treat disorders caused by disturbances in blood rheological properties, particularly relating to blood viscosity and erythrocyte flexibility. This is especially beneficial for patients suffering from microangiopathy, diabetes, and those undergoing dialysis.

Career Highlights

Conrad's career at Asta Medica Aktiengesellschaft has allowed him to develop and refine his innovative approaches in medical science. His expertise in the field has contributed to advancements in treatments aimed at enhancing erythrocyte function and overall patient health.

Collaborations

Frank Conrad has collaborated with esteemed colleagues, including Hermann-August Henrich and Wolfgang Geise. These partnerships have enabled a synergy of ideas and research, leading to significant breakthroughs in the study of blood properties and treatment methodologies.

Conclusion

Frank Conrad's inventions and patents exemplify the vital role of innovation in medicine, particularly in the specialized area of hematology. His work at Asta Medica, alongside his dedicated colleagues, continues to inspire advancements that can improve patient outcomes and enhance the efficacy of treatments related to blood disorders.